This article first appeared on GuruFocus .
-
Revenue:$216 million, up 3% year-over-year and sequentially, above the high end of guidance.
-
IC Revenue:$155 million, up nearly 5% year-over-year and sequentially, representing 72% of total revenue.
-
High-End IC Revenue:Record 44% of IC revenue.
-
Mainstream IC Revenue:$86 million, declined due to node migration trends.
-
FPD Revenue:$61 million, declined modestly but remains near all-time highs.
-
Gross Margin:33%, improved sequentially on product mix and increased revenue.
-
Operating Margin:21%.
-
Diluted GAAP EPS:$0.49 per share.
-
Non-GAAP Diluted EPS:$0.50 per share, excluding foreign exchange impacts.
-
Operating Cash Flow:$76 million, representing 35% of revenue.
-
CapEx:$37 million in the quarter; fiscal year-to-date $130 million.
-
CapEx Guidance (Fiscal 2026):Updated to a range of $255 million to $305 million.
-
Cash and Short-Term Investments:Increased by $35 million to $673 million.
-
Fiscal Q4 Revenue Guidance:$207 million to $227 million.
-
Fiscal Q4 Operating Margin Guidance:19% to 24%.
-
Fiscal Q4 Non-GAAP Diluted EPS Guidance:$0.40 to $0.56 per share.
Release Date: August 26, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Photronics Inc ( NASDAQ:PLAB ) reported fiscal Q3 revenue of $216 million, a 3% year-over-year increase that exceeded the high end of guidance, driven by recovery in delayed semiconductor design releases.
-
High-end IC business achieved a record 44% of IC revenue ($155 million), benefiting from node migration trends at 28, 22, and 14 nanometer across diverse geographic locations.
-
FPD revenue of $61 million remained near all-time highs, supported by strong OLED demand from flagship smartphones and additional G8.6 AMOLED orders from a growing customer base.
-
The company's most advanced FPD writer entered mass production during the quarter, receiving strong market traction and aligning with customer technology roadmaps.
-
Operating cash flow was robust at $76 million (35% of revenue), and total cash and short-term investments increased by $35 million to $673 million, providing significant financial strength for planned investments.
-
Regionalized investments in the US (Allen facility) and Korea (8-nanometer expansion) remain on track, with Allen targeting initial revenue late this fiscal quarter and Korea's cleanroom preparation substantially completed.
Negative Points
-
Photronics Inc ( NASDAQ:PLAB ) faces ongoing challenges from high fab utilization rates, memory constraints, and geopolitical uncertainty, which continue to affect the photomask industry and limit visibility into design release timelines.
-
Mainstream IC business declined to $86 million due to node migration trends, reflecting a shift away from lower-ASP products.
-
FPD revenue in China was impacted by timing of consumer electronics releases for emerging markets, disrupted by tight memory conditions.
-
The company widened its fiscal Q4 revenue guidance range to $207 million-$227 million due to increased uncertainty, indicating potential volatility in results.
-
Fiscal 2026 CapEx guidance was reduced to $255 million-$305 million from $330 million due to vendor delivery timing, with some spending potentially shifting to fiscal 2027, which could delay expected returns.
-
Gross margin of 33% improved sequentially but remains under pressure from market and geographic mix, with Q4 operating margin expected between 19% and 24%, reflecting potential variability.
Q & A Highlights
Q: Can you elaborate on the partnerships mentioned, particularly regarding EUV technology, and when you expect to be fully ramped on that technology? A: George Macricostas, Chairman and CEO, clarified that the partnerships are specific to EUV. The company is monitoring the merchant market's development to ensure it is economically viable before making significant investments for a full turnkey EUV capability. They are currently using industry partnerships to supply EUV R&D masks and solutions while waiting for the market to mature, with more details expected in future quarters.
Q: Regarding the Allen, Texas facility, what is the potential revenue capacity when fully utilized, and how will it impact the company's operations? A: Eric Rivera, President and CFO, declined to provide specific revenue capacity figures but explained that the expansion will increase capacity at the higher end of the mainstream market. This will allow the Boise facility to focus more on high-end nodes, effectively growing both mainstream high-end and high-end revenues. George Macricostas added that Allen will service mid-range nodes (e.g., 65nm), while Boise will focus on more critical high-end nodes like 14nm.
Q: Are the design releases that were delayed in Q2 now fully caught up, and what is the current market outlook? A: Eric Rivera confirmed that most design releases delayed from Q2 did come through in Q3, which helped results. However, the underlying conditions that caused the delayshigh fab utilization rates, high memory costs, and geopolitical uncertaintystill largely remain, indicating ongoing challenges and limited visibility.
Q: Why the focus on EUV now, and how much incremental capital spending is expected on top of the $255 million to $305 million CapEx guidance? A: Eric Rivera explained that the company is waiting for the EUV merchant market to develop before making significant investments for a full turnkey capability, as these require substantial CapEx. In the meantime, they are providing EUV services via partnerships. The company wants to ensure appropriate internal rates of return before diving into full EUV investments.
Q: When Allen starts generating revenue in Q4, will that be from new customers or from mid-range work moving over from Boise, and how much is incremental? A: Eric Rivera noted that the customers are largely the same, with a few exceptions. The work will be incremental to Allen, and more importantly, it will help grow Boise's high-end business. The additional capacity allows for expansion at the high end of mainstream and enables Boise to focus on more advanced nodes.
Q: On the China side, was the decline mainly in mainstream, and is there competition on the high-end business as well? A: Eric Rivera stated that the China market is competitive primarily on the mainstream, with local mask houses as competitors. Over the past 1.5 to 2 years, Photronics has focused its efforts on the high end, where it holds a competitive advantage and technology leadership.
Q: Are customers ordering complete mask sets or partial respins for mainstream designs? A: Eric Rivera confirmed that customers are typically ordering complete mask sets rather than partial respins.
Q: What is driving the wider Q4 revenue guidance range of $207 million to $227 million, and why is visibility lower than in previous quarters? A: Eric Rivera attributed the wider range to persistent market conditions: high fab utilization rates, high memory costs, and geopolitical uncertainty. George Macricostas added that a single high-end mask set can be worth a couple of million dollars or more, which can cause significant quarterly swings, making results choppier and less predictable.
Q: Regarding end-of-life tool upgrades, is there any shift in the expected peak from 2026 to next year? A: Eric Rivera confirmed that some CapEx is expected to shift into fiscal 2027 due to ordering patterns and vendor delivery schedules. As a result, the peak of capital expenditures may occur in 2027 rather than 2026.
Q: What caused the gross margin compression in Q4 last year despite similar revenue levels, and what should we expect going forward? A: Eric Rivera explained that gross margins are driven by volumes and market mix, including both product mix and geographic mix of where revenue and earnings occur. The combination of these factors, rather than a single cost item, drives margin performance.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
